Based on an average market stock price of $15.19 per share, the total value of the transaction is approximately $75,950.
Mr. Wilver, who serves as executive vice president and chief administrative officer of Waltham, Mass.-based Thermo Fisher Scientific, was recently appointed to Tenet’s board of independent directors along with John P. Byrnes. Tenet’s board now consists of 14 directors, 13 of whom are independent.
More articles on healthcare finance:
6 strategies for hospital financial planning in an era of value, consumerism and growing drug costs
The most pressing issues for CFOs in 2017
Fair market value considerations for 6 steps of bundled payment program development
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.